-
PCV (Pneumococcal Conjugate)
-
Pneumococcal
Current
Expanded Recommendations for Use of Pneumococcal Conjugate Vaccines among Adults aged ≥50 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024
MMWR January 9, 2025;74:1–8
Current
Use of Additional Doses of 2024–2025 COVID-19 Vaccine for Adults Aged ≥65 Years and Persons Aged ≥6 Months with Moderate or Severe Immunocompromise: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024
MMWR December 12, 2024 / 73(49);1118–1123
Current
New Dosing Interval and Schedule for the Bexsero MenB-4C Vaccine: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, October 2024
MMWR December 12, 2024 / 73(49);1124–1128
Current
Updated Recommendation for Universal Hepatitis B Vaccination in Adults Aged 19–59 Years — United States, 2024
MMWR Weekly / December 5, 2024 / 73(48);1106
-
Hib (Haemophilus Influenzae Type B)
Current
Use of Haemophilus influenzae Type b–Containing Vaccines Among American Indian and Alaska Native Infants: Updated Recommendations of the Advisory Committee on Immunization Practices ― United States, 2024
MMWR September 12, 2024 / 73(36);799–802
-
PCV (Pneumococcal Conjugate)
-
Pneumococcal
Current
Use of 21-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024
MMWR September 12, 2024 / 73(36);793–798
Current
Use of COVID-19 Vaccines for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024–2025
MMWR: Early Release September 10, 2024, 73
Current
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices—United States, 2024–25 Influenza Season
MMWR: August 29, 2024;73(No. RR-5):1–25
-
RSV (Respiratory Syncytial Virus)
Current
Use of Respiratory Syncytial Virus Vaccines in Adults Aged ≥60 Years: Updated Recommendations of the Advisory Committee on Immunization Practices— United States, 2024
MMWR August 15, 2024 / 73(32);696-702
Archived
Use of an Additional Updated 2023–2024 COVID-19 Vaccine Dose for Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024
MMWR, April 25, 2024 / 73(16);377–381
-
Meningococcal ACWY
-
Meningococcal B
Current
Use of the Pfizer Pentavalent Meningococcal Vaccine Among Persons Aged ≥10 Years: Recommendations of the Advisory Committee on Immunization Practices ― United States, 2023
MMWR April 18, 2024 / 73(15);345–350
Current
Use of Inactivated Polio Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2023
MMWR December 8, 2023 / 72(49);1327–1330
-
TBE (Tick-Borne Encephalitis)
Current
Tick-Borne Encephalitis Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023
MMWR November 10, 2023 / 72(5);1–29
Archived
Use of Updated COVID-19 Vaccines 2023–2024 Formula for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2023
MMWR: October 20, 2023 / 72(42);1140–1146
-
RSV (Respiratory Syncytial Virus)
Current
Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus–Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023
MMWR, October 13, 2023, 72(41);1115-1122
Archived
COVID-19 Vaccination Recommendations and Practices for Women of Reproductive Age by Health Care Providers — Fall DocStyles Survey, United States, 2022
MMWR: September 29, 2023 / 72(39);1045–1051
-
PCV (Pneumococcal Conjugate)
-
Pneumococcal
Current
ACIP Updates: Recommendations for Use of 20-Valent Pneumococcal Conjugate Vaccine in Children ― United States, 2023
MMWR. September 29, 2023 / 72(39);1072
-
PCV (Pneumococcal Conjugate)
-
Pneumococcal
-
PPSV (Pneumococcal Polysaccharide)
Current
Pneumococcal Vaccine for Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023.
MMWR. September 8, 2023 / 72(RR-3);1–39
Archived
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices—United States, 2023–24 Influenza Season
MMWR; August 25, 2023;72(RR-2);1-25
-
RSV (Respiratory Syncytial Virus)
Current
Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices—United States, 2023
MMWR, August 25, 2023, 72(34); 920–925
-
RSV (Respiratory Syncytial Virus)
Current
Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices
MMWR, July 21, 2023, 72 (29); 793-801
Archived
Interim Recommendations for Use of Bivalent mRNA COVID-19 Vaccines for Persons Aged ≥6 Months — United States, April 2023
MMWR: June 16, 2023 / 72(24);657–662
Current
Measles, Mumps, Rubella Vaccine (PRIORIX): Recommendations of the Advisory Committee on Immunization Practices—United States, 2022
MMWR, November 18, 2022, 71 (46); 1465-1470
Archived
ACIP Interim Recommendations for the Use of Bivalent Booster Doses of COVID-19 Vaccines—United States, October 2022
MMWR, November 11, 2022, 71(45);1436-1441
Current
Cholera Vaccine: Recommendations of the Advisory Committee on Immunization Practices, 2022
MMWR, September 30, 2022, 71 (2); 1-8
-
PCV (Pneumococcal Conjugate)
-
Pneumococcal
Current
Use of 15-Valent Pneumococcal Conjugate Vaccine Among U.S. Children: Updated Recommendations of the Advisory Committee on Immunization Practices—United States, 2022
MMWR, September 16, 2022, 71(37);1174–1181
Archived
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices—United States, 2022–23 Influenza Season
MMWR, August 26, 2022, 71(1); 1-28
Archived
ACIP Interim Recommendation for Use of the Novavax COVID-19 Vaccine in Adults 18 years and older — US, July 2022
MMWR, August 5, 2022, 71(31);988–992
Archived
ACIP Interim Recommendations for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months–5 Years — United States, June 2022
MMWR Early Release June 28, 2022
-
Mpox (Monkeypox)
-
Smallpox
Current
Use of Jynneos (smallpox and monkeypox vaccine, live, nonreplicating) for preexposure vaccination of persons at risk for occupational exposure to orthopoxviruses: Recommendations of the Advisory Committee on Immunization Practices — US, 2022
MMWR, May 27, 2022, Vol 71
Current
Use of a Modified Preexposure Prophylaxis Vaccination Schedule to Prevent Human Rabies: Recommendations of the Advisory Committee on Immunization Practices — US, 2022
MMWR, May 6, 2022, 71(18);619–627
Current
Universal Hepatitis B Vaccination in Adults Aged 19–59 Years, updated ACIP recommendations
MMWR, April 1, 2022, 71(13);477–483
Archived
ACIP Recommendation for use of Moderna COVID-19 Vaccine in Adults aged 18 years and older, considerations for extended intervals for primary series doses of mRNA COVID-19 vaccines — US, February 2022
MMWR, March 18, 2022, 71 (11); 416-421
Current
Use of Ebola Vaccine: Expansion of ACIP Recommendations to include two additional populations, US, 2021
MMWR, February 25, 2022, 71(8);290–292
-
PCV (Pneumococcal Conjugate)
-
Pneumococcal
Current
Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices
MMWR, January 28, 2022, 71 (4); 109-117
Archived
ACIP Updated Interim Recommendations for Use of the Janssen (Johnson & Johnson) COVID-19 vaccine, US, December 2021
MMWR, January 21, 2022, 71(3);90-95
Current
ACIP Recommendations for Use of Recombinant Zoster Vaccine (RZV, Shingrix, GSK) in Immunocompromised Adults aged 19 years and older, US, 2022
MMWR, January 21, 2022, 71(3);80-84
Current
ACIP Recommendations on Dengue Vaccine, US, 2021
MMWR December 17, 2021, 70(6);1–16
Archived
ACIP Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5–11 Years - US, 2021
MMWR Early Release, November 5, 2021, 70
Archived
Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged 16 Years and older: Recommendations of the Advisory Committee on Immunization Practices — U.S., September 2021
MMWR Early Release, September 21, 2021
Archived
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2021–22 Influenza Season
MMWR, August 27, 2021, 70(5); 1–28
Archived
Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from ACIP — US, July 2021
MMWR, August 13, 2021, 70(32);1094-1099
Archived
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from ACIP — US, June 2021
MMWR Early Release, July 6, 2021
Archived
ACIP Interim Recommendations for use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12–15 years, US, May 2021
MMWR Early Release, May 14, 2021, 70
Archived
Updated Recommendation from ACIP for Use of Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients — U.S. April 2021
MMWR Early Release, April 27, 2021, 70
Archived
ACIP Interim Recommendation for Use of Janssen (Johnson and Johnson) COVID-19 Vaccine - U.S., February 2021
MMWR, March 2, 2021, 70
Current
Use of Ebola Vaccine: Recommendations of the Advisory Committee on Immunization Practices, U.S., 2020
MMWR, January 8, 2021,70(1);1–12
Archived
ACIP Updated Interim Recommendation for Allocation of COVID-19 Vaccine – U.S., December 2020
MMWR, December 22, 2020, 69
Archived
ACIP Interim Recommendation for Use of Moderna COVID-19 Vaccine – U.S, December 2020
MMWR, December 20, 2020, 69
Archived
ACIP Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine – U.S., December 2020
MMWR, December 13, 2020, 69
Archived
ACIP Interim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine – U.S., 2020
MMWR, December 3, 2020, 69
-
Meningococcal ACWY
-
Meningococcal B
Current
Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020
MMWR, September 25, 2020, Volume 69(9); 1–41
Archived
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2020–21 Influenza Season
MMWR, August 21, 2020, 69 (8); 1–24
Current
Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2020
MMWR, July 3, 2020, Vol 69 (5);1-38
-
Diphtheria
-
Hepatitis B
-
Hib (Haemophilus Influenzae Type B)
-
Pertussis
-
Polio
-
Tetanus
Current
Licensure of a Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus influenzae Type b Conjugate, and Hepatitis B Vaccine, and Guidance for Use in Infants
MMWR, February 7, 2020, 69 (5);136-139
-
Diphtheria
-
Pertussis
-
Tetanus
Current
Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2019
MMWR, January 24, 2020, Vol 69 (3);77-83
Current
Use of Anthrax Vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2019
MMWR, December 13, 2019, 68(4);1–14
-
PCV (Pneumococcal Conjugate)
-
Pneumococcal
-
PPSV (Pneumococcal Polysaccharide)
Current
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged 65 Years and older: Updated Recommendations of the Advisory Committee on Immunization Practices
MMWR, November 22, 2019; 68(46):1069–1075
Archived
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2019–20 Influenza Season
MMWR, August 23, 2019, 68(3); 1–21
-
HPV (Human Papillomavirus)
Current
Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices
MMWR August 16, 2019; 68(32): 698–702
-
Japanese Encephalitis (JE)
Current
Japanese Encephalitis Vaccine: Recommendations of the Advisory Committee on Immunization Practices
MMWR, July 19, 2019, 68(2); 1-33
Current
Interim Infection Prevention and Control Recommendations for Measles in Healthcare Settings
CDC Infection Control Guideline Library - July 2019
Archived
Recommendations of the Advisory Committee on Immunization Practices for Use of Hepatitis A Vaccine for Persons Experiencing Homelessness
MMWR, February 15, 2019; 68(6);153–156
Archived
Update: Recommendations of the Advisory Committee on Immunization Practices for Use of Hepatitis A Vaccine for Postexposure Prophylaxis and for Preexposure Prophylaxis for International Travel
MMWR, November 2, 2018; 67(43);1216–1220
Archived
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2018–19 Influenza Season
MMWR, August 24, 2018, 67(3); 1-20
